Exact Mass: 305.9736
Exact Mass Matches: 305.9736
Found 167 metabolites which its exact mass value is equals to given mass value 305.9736,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2,2-Dichloro-N-[2-hydroxy-1-(hydroxymethyl)-2-(4-nitrosophenyl)ethyl]acetamide
(-)-Mintlactone
(-)-mintlactone is a member of the class of compounds known as benzenesulfonyl compounds. Benzenesulfonyl compounds are aromatic compounds containing a benzenesulfonyl group, which consists of a monocyclic benzene moiety that carries a sulfonyl group (-)-mintlactone is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). (-)-mintlactone can be found in peppermint, which makes (-)-mintlactone a potential biomarker for the consumption of this food product.
ascidiathiazone B
An organic heterotricyclic compound, that is 5,10-dioxo-5,10-dihydro-1H-[1,4]thiazino[3,2-g]quinoline 4,4-dioxide substituted at position 7 by a carboxy group. It is an anti-inflmmatory alkaloid obtained from Aplidium.
Broxuridine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent D009676 - Noxae > D000963 - Antimetabolites D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.233 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.226 5-BrdU (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA. 5-BrdU is commonly used in the detection of proliferating cells.
4,4,5,5-tetramethyl-2-(2,4,6-trichlorophenyl)-1,3,2-dioxaborolane
3,5-Bis(trifluoromethyl)phenyldimethylchlorosilane
4-[3-(2,4-Dichlorophenyl)isoxazol-5-yl]pyrimidin-2-amine
Rimoprogin
C254 - Anti-Infective Agent > C514 - Antifungal Agent
tert-butyl N-(4-bromo-5-formyl-1,3-thiazol-2-yl)carbamate
3-(4-BROMOPHENYL)-5-(THIOPHEN-2-YL)-1,2,4-OXADIAZOLE
2-(4-CHLOROPHENYL)-4,4-BIS(METHYLTHIO)-1,3-BUTADIEN-1,1-DICARBONITRILE
Sodium 5-oxo-1-(4-sulfophenyl)-4H-pyrazole-3-carboxylate
Glycine,N-[(2,3-dichloro-6-nitrophenyl)methyl]-, ethyl ester, hydrochloride (1:1)
2-(2-chloro-6-fluorobenzyl)-4,5-dichloropyridazine-3-(2h)-one
4-(S)-1-Des(methylamine)-1-oxo-2-(R,S)-hydroxy Sertraline
tert-Butyl (2-bromo-6-chloropyridin-3-yl)carbamate
Thiazolo[5,4-g]quinoline-7-carboxylic acid,5-ethyl-2,3,5,8-tetrahydro-8-oxo-2-thioxo-
N-(5-bromo-2-methoxypyridin-3-yl)cyclopropanesulfonamide
ACETIC ACID ACETOXY-(4-CHLORO SULFONYL PHENYL)METHYL ESTER
Cyclohexadienyliumiron(0) tricarbonyl tetrafluoroborate
methyl 2-(trimethylstannyl)thiophene-3-carboxylate
TERT-BUTYL (5-BROMO-2-CHLOROPYRIDIN-3-YL)CARBAMATE
3-(3-Bromo-4-methoxyphenyl)benzoic acid, 2-Bromo-4-(3-carboxyphenyl)anisole, 3-Bromo-3-carboxy-4-methoxybiphenyl
5-[2-(METHYLTHIO)PYRIMIDIN-4-YL]THIOPHENE-2-SULFONYL CHLORIDE
(5-BROMO-2-HYDROXY-4-METHOXYPHENYL)(PHENYL)METHANONE
2-(3-Bromophenyl)-5-(thiophen-2-yl)-1,3,4-oxadiazole
2-[(2-bromophenyl)methoxy]benzoic Acid
ML-097 (CID-2160985) is a pan Ras-related GTPases activator that can activate Rac1, cell division cycle 42, Ras, and Rab7[1].
5-chloro-N-(1,3-dioxo-5-isoindolyl)-2-thiophenecarboxamide
Technetium TC-99M medronate
V - Various > V09 - Diagnostic radiopharmaceuticals > V09B - Skeleton > V09BA - Technetium (99mtc) compounds D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates
N-(3-chloro-4-fluorophenyl)-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine
3-chloro-4-fluoro-N-(3-pyridinyl)-1-benzothiophene-2-carboxamide
D-ribulose 1,5-bisphosphate(4-)
Tetraanion of D-ribulose 1,5-bisphosphate arising from deprotonation of all four phosphate OH groups; major species at pH 7.3.
2′-Bromo-2′-deoxyuridine
2′-Bromo-2′-deoxyuridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
